找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Chemotherapy and Urological Malignancy; A. S. D. Spiers (Professor of Medicine) Book 1982 Springer-Verlag Berlin Heidelberg 1982 Urogenita

[復制鏈接]
樓主: 退縮
21#
發(fā)表于 2025-3-25 04:47:27 | 只看該作者
Chemotherapy of Cancer of the Prostate,he expected annual incidence is 42000 new cases with 17000 deaths. It has been estimated that 30% of cases are potentially curable when first discovered but this is open to serious question (Klein 1979). Between 1950 and 1970 the reported incidence of prostatic carcinoma rose from 17 to 21 per 10000
22#
發(fā)表于 2025-3-25 09:48:12 | 只看該作者
23#
發(fā)表于 2025-3-25 13:44:20 | 只看該作者
,Urological Oncology — A European View,ontinuing financial support from the National Cancer Institute (NCI) in Bethesda. It has also been aided in the last 5 years by private donations collected by the EORTC foundation and, since 1979, has had official support from the European Community.
24#
發(fā)表于 2025-3-25 15:55:56 | 只看該作者
25#
發(fā)表于 2025-3-25 23:50:27 | 只看該作者
Chemotherapy and Urological Malignancy978-1-4471-1332-4Series ISSN 0177-8994
26#
發(fā)表于 2025-3-26 01:46:23 | 只看該作者
Quick Guide to the Management of Keratoconusontinuing financial support from the National Cancer Institute (NCI) in Bethesda. It has also been aided in the last 5 years by private donations collected by the EORTC foundation and, since 1979, has had official support from the European Community.
27#
發(fā)表于 2025-3-26 04:46:45 | 只看該作者
https://doi.org/10.1007/978-1-4471-1332-4Urogenitalkrebs; Zytostatikum; cancer; carcinoma; chemotherapy; kidney; prostate; tumor
28#
發(fā)表于 2025-3-26 10:50:05 | 只看該作者
29#
發(fā)表于 2025-3-26 15:42:54 | 只看該作者
Dynamic Asset Allocation with Credit Riskence of this tumor is only 0.2/100,000. However, the propensity for adrenal cortical carcinoma to excrete hormones has led to unique groups of drugs which produce significant palliation of bothersome and life-threatening endocrinologically induced symptoms. Cushing’s syndrome, virilization, feminiza
30#
發(fā)表于 2025-3-26 20:20:08 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-13 09:01
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
东辽县| 洱源县| 湘潭市| 边坝县| 舟曲县| 漾濞| 宜州市| 大同市| 元氏县| 海伦市| 昭苏县| 同江市| 浠水县| 玉山县| 益阳市| 蓬莱市| 江西省| 万年县| 尚义县| 静宁县| 陕西省| 临朐县| 容城县| 通江县| 汉寿县| 海原县| 荔浦县| 德惠市| 曲靖市| 绥化市| 武隆县| 枣庄市| 潞城市| 绍兴县| 宁陕县| 定州市| 北票市| 平度市| 集安市| 上虞市| 七台河市|